---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-032448"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:12:37.846972+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BIO-key raises $3.1M via warrant exercise, exchanges debt for equity

## Summary
- Gross proceeds $3.1M from exercise of 3,091,668 warrants at reduced exercise price of $1.02; new warrants for 6.18M shares at $1.02.
- Net proceeds for working capital and debt repayment; $0.25 per warrant paid for new warrants.
- Streeterville Capital exchanged $327,991 secured note principal for 429,027 shares; original note paid in full.
- New warrants expire in 5 years; resale registration to be filed within 90 days.
- Transactions in unregistered offering; Maxim Group earned 6% fee on gross proceeds.

## SEC filing metadata
- accession: 0001437749-25-032448
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774925032448/0001437749-25-032448-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774925032448/bkyi20251029_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-032448
- JSON: https://secwatch.observer/filing/0001437749-25-032448.json
- Plain text: https://secwatch.observer/filing/0001437749-25-032448.txt

## Key facts
- Equity Issuances
  BIO KEY INTERNATIONAL INC issued 429,027 shares of common stock to Streeterville Capital, LLC.
  - Security: common stock
  - Shares: 429,027 shares
  - Purchaser: Streeterville Capital, LLC
  source text: exchange (the “Exchange”) the Partitioned Notes for an aggregate of 429,027 shares (the “Exchange Shares”) of the Company’s Common Stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1019034/000143774925032448/0001437749-25-032448-index.htm
- Equity Issuances
  BIO KEY INTERNATIONAL INC issued 3,091,668 shares of common stock to existing institutional investor.
  - Security: common stock
  - Shares: 3,091,668 shares
  - Purchaser: existing institutional investor
  source text: On October 27, 2025, BIO-key International, Inc. (the “Company”) entered into a warrant exercise agreement (the “Warrant Exercise Agreement”) with an existing institutional investor (the “Investor”) to exercise certain outstanding warrants to purchase an aggregate of 3,091,668 shares of the Company’s common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1019034/000143774925032448/0001437749-25-032448-index.htm
- Equity Issuances
  BIO KEY INTERNATIONAL INC issued 6,183,336 shares of warrant to existing institutional investor for combined purchase price of $0.25 per Existing Warrant.
  - Security: warrant
  - Shares: 6,183,336 shares
  - Purchaser: existing institutional investor
  - Consideration: combined purchase price of $0.25 per Existing Warrant
  source text: Warrants, subject to compliance with the beneficial ownership limitations included in the Existing Warrants, and the payment by the Investor of the combined purchase price of $0.25 per Existing Warrant (the “New Warrant Consideration”), the Investor received new unregistered warrants to purchase up to an aggregate of 6,183,336 shares of the Company’s Common
  evidence_url: https://www.sec.gov/Archives/edgar/data/1019034/000143774925032448/0001437749-25-032448-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.